Current Firm
Refactor Capital
Investments
1+ companies
Focus
Biotech, Digital Health
Zal Bilimoria is a solo GP at Refactor Capital who combines deep technical experience from building products at Microsoft and Google with a specific focus on non-human genomics, synthetic biology, and hard science investments that most software-focused seed investors avoid. He approaches investing through an engineering lens, using concepts like "refactoring" and "debugging" to help founders redesign foundational systems in health, food, and climate, while treating the venture capital process itself as a product experience by measuring founder satisfaction through systematic Net Promoter Score tracking.
Zal Bilimoria is a Founding Partner, Refactor Capital at Refactor Capital, based in San Francisco, CA.
Zal's investment focus spans Biotech, Digital Health, Climate, Deeptech, primarily investing at the Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments in Zal's portfolio include Astranis. These companies reflect a pattern of backing high-potential startups across their focus sectors.
Zal Bilimoria is a Founding Partner, Refactor Capital at Refactor Capital, based in San Francisco, CA. Their investment focus includes Biotech, Digital Health, Climate.
Zal Bilimoria focuses on investments in Biotech, Digital Health, Climate, Deeptech through Refactor Capital. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Zal Bilimoria's notable portfolio investments include Astranis. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Zal Bilimoria is currently at Refactor Capital, headquartered in San Francisco, CA, serving as Founding Partner, Refactor Capital.